Dr Reddys Laboratories (RDY) Shares Outstanding (Entity) (2009 - 2026)
Dr Reddys Laboratories (RDY) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 414.15 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.68 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.15 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.60 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.55 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 834.66 Mn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 167.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 834.66 Mn |
| Mar 31, 2025 | 834.46 Mn |
| Mar 31, 2024 | 834.09 Mn |
| Mar 31, 2023 | 832.64 Mn |
| Mar 31, 2022 | 832.13 Mn |
| Mar 31, 2021 | 831.51 Mn |
| Mar 31, 2020 | 9.00 |
| Mar 31, 2019 | 9.00 |
| Mar 31, 2018 | 9.00 |
| Dec 31, 2017 | 1.00 |
| Mar 31, 2016 | 9.00 |
| Sep 30, 2015 | 5.00 |
| Jun 30, 2015 | 5.00 |
| Mar 31, 2015 | 9.00 |
| Dec 31, 2014 | 5.00 |
| Sep 30, 2014 | 5.00 |
| Mar 31, 2014 | 9.00 |
| Dec 31, 2013 | 9.00 |
| Sep 30, 2013 | 9.00 |
| Jun 30, 2013 | 9.00 |